CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing preference for minimally invasive surgeries
4.1.2. Increasing number of initiatives to grow awareness about artificial tendons and
ligaments
4.1.3. Rising incidence of sports injuries
4.1.4. Increasing research activities on artificial tendons and ligaments
4.2. Market Restraints & Challenges
4.2.1. Reluctance to use artificial tendons and ligaments among healthcare providers
4.2.2. High procedure costs and unfavourable reimbursement scenario across major markets.
4.2.3. Lack of trained professionals and limited clinical evidence to support the efficacy of
artificial tendons and ligaments.
4.3. Market Opportunities
4.3.1. Expansion and market penetration opportunities in the emerging nations
CHAPTER 5. GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET – BY
APPLICATION
5.1. Shoulder injuries
5.2. Knee Injuries
5.3. Foot and ankle injuries
5.4. Others
CHAPTER 6. GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET - BY
GEOGRAPHY
6.1. Introduction
6.2. North America
6.2.1. U.S.
6.2.2. Canada
6.2.3. Mexico
6.2.4. Costa Rica
6.3. South America
6.3.1. Brazil
6.3.2. Argentina
6.3.3. Chile
6.3.4. Columbia
6.3.5. Others
6.4. Europe
6.4.1. U.K.
6.4.2. Germany
6.4.3. France
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Netherlands
6.4.8. Switzerland
6.4.9. Poland
6.4.10. Others
6.5. APAC
6.5.1. China
6.5.2. Japan
6.5.3. India
6.5.4. South Korea
6.5.5. Australia & New Zealand
6.5.6. Malaysia
6.5.7. Singapore
6.5.8. Others
6.6. Middle East & Africa
6.6.1. UAE
6.6.2. Saudi Arabia
6.6.3. Iran
6.6.4. Iraq
6.6.5. Qatar
6.6.6. South Africa
6.6.7. Algeria
6.6.8. Morocco
6.6.9. Nigeria
6.6.10. Egypt
6.6.11. Others
CHAPTER 7. GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET -
COMPANY PROFILES
7.1. LARS Inc.
7.2. Neoligaments Ltd.
7.3. Orthomed S.A.S
7.4. FX Solutions LLC
7.5. Shanghai PINE&POWER Biotech Co., Ltd.
7.6. Mathys AG Bettlach
7.7. Arthrex, Inc.
7.8. Arthocare Corporation
7.9. FH Orthopedics
7.10. Cousin Biotech
CHAPTER 8. GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET -
COMPETITIVE LANDSCAPE
8.1. Market Share Analysis
8.2. Strategies adopted by top companies
8.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 9. MARKET INSIGHTS
9.1. Industry Experts Insights
9.2. Analysts Opinions
9.3. Investment Opportunities
CHAPTER 10. APPENDIX
10.1. List of Tables
10.2. List of Figures
